Literature DB >> 11881503

[Dysbioses of the oral cavity and intestines and immune reactivity in of adolescent bronchial asthma patients].

T V Gavrish1.   

Abstract

Sixty bronchial asthma (BA) patients aged 15-18 years were examined between attacks. The composition of the oral cavity and intestine microflora as well as the total IgE level, peripheral blood eosinophils and lymphocytes expressing receptors CD3, CD4, CD8, CD22, CD11b, CD71, HLA-DR were detected. Colonization of the oral cavity by Staphylococcus aureus in 9%, by hemolytic streptococci in 10%, by fungi of the genus Candida in 25% and by enterococci in 7% of the patients was revealed. From the intestines S. aureus were isolated in 21%, hemolytic Escherichia coli in 18% and fungi of the genus Candida from 45% of the patients, while lactic acid bacteria were isolated only in 39% of the patients. The patients of this group were found to have eosinophilia (4.21 +/- 0.05%, p < 0.001) and a high concentration of IgE (330.2 +/- 29.31%, p < 0.01); in these patients the index CD4/CD8 was lower (< 0.05), the number of CD11b-, CD71- and HLA-DR positive lymphocytes was elevated. Thus, at periods between attacks the examined BA patients were found to have dysbiosis of mucous membranes, an elevated content of IgE, eosinophilia and lymphocyte activation indicative of the absence of immunological remission and required adequate diagnostic and therapeutic measures.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11881503

Source DB:  PubMed          Journal:  Zh Mikrobiol Epidemiol Immunobiol        ISSN: 0372-9311


  1 in total

1.  Specific Link between Lung and Large Intestine: A New Perspective on Neuropeptide Secretion in Lung with Herbal Laxative Stimulation.

Authors:  Xiang-Gen Zhong; Feng-Jie Zheng; Yu-Hang Li; Hong Xu; Qian Wang; Yu-Chao Liu; Miao Liu; Ruo-Han Wu; Yu-Shan Gao; Shu-Jing Zhang; Jin-Chao Zhang; Tian-Yu Zhang; Si-Hua Gao
Journal:  Evid Based Complement Alternat Med       Date:  2013-08-20       Impact factor: 2.629

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.